logo

For the Inventor, By the Inventor

Milan, Italy

Giorgio Pifferi

This inventor holds 28 USPTO granted patents, primarily in Pharmaceutical Compositions. Top assignees: Isf LLC, Gruppo Lepetit, Inverni Della Beffa Spa. Active years: 1976-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Giorgio Pifferi. Retrieved from https://idiyas.com/inventor/giorgio-pifferi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28

% Patents Active = 96.4

Average Co-Inventor Count = 2.5

ph-index = 8

Forward Citations = 277(Granted Patents)


Location History:

  • Milan, I (1976)
  • Milan, IT (1976 - 2007)

Company Filing History:

goldMedal12 out of 19 
 
Isf LLC
 patents
silverMedal5 out of 188 
 
Gruppo Lepetit
 patents
bronzeMedal4 out of 21 
 
Inverni Della Beffa Spa
 patents
4. 3 out of 3 
 
Craf Sud
 patents
5. 2 out of 5 
 
I D B Holding S.p.a.
 patents
6. 1 out of 106 
 
Aziende Chimiche Riunite Angelini Francesco A.c.r.a.f. S.p.a.
 patents
7. 1 out of 1 
 
Inverni Della Beefa S.p.a.
 patent

Years Active: 1976-2007

Loading Chart...
Areas of Expertise:
Pharmaceutical Compositions
Controlled Release
Anti-Inflammatory Agents
Xanthone Derivatives
Silybin Derivatives
Hydrazinopenicillins
Cephalosporins
Triazole Derivatives
Pyrrolidine Derivatives
Flavanolignans
Benzothiazepine Esters
28 patents (USPTO):Explore Patents
1. 7250428 - Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it (2007-07-31),
2. 5549913 - Multilayer matrix systems for the controlled release of active principles (1996-08-27),
3. 5516794 - Xanthone derivatives, their preparation and use (1996-05-14),
4. 5196449 - Methods and pharmaceutical compositions for the treatment of ophthalmic (1993-03-23),
5. 5120730 - Benzothiazepine esters, their preparation and formulations for (1992-06-09),
6. 4886791 - Soluble derivatives of silybin, a method of preparing them, and (1989-12-12),
7. 4879311 - Derivatives of benzoyloxyacetic acid, and preparation and formulations (1989-11-07),
8. 4764508 - Complexes of flavanolignans with phospholipids, preparation thereof and (1988-08-16),
9. 4632982 - Triphenylmethyl azo and hydrazino substituted pyridazines (1986-12-30),
10. 4575552 - Process of making (1986-03-11),
11. 4530934 - Pharmaceutically active ursolic acid derivative (1985-07-23),
12. 4329285 - Formyl derivatives of hydrazinopenicillins (1982-05-11),
13. 4324788 - Alkoxyalkylidenhydrazinopridazines and process for their preparation (1982-04-13),
14. 4231927 - Hydrazono penicillin derivatives (1980-11-04),
15. 4178444 - Hydrazono derivatives of cephalosporins (1979-12-11),

Title: Giorgio Pifferi - Innovator from Milan, Italy

Introduction: Giorgio Pifferi is a renowned inventor hailing from Milan, Italy, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Giorgio Pifferi holds several patents in the areas of biophotonics, spectroscopy, and medical devices, showcasing his continuous dedication to pushing the boundaries of scientific discovery.

Career Highlights: With a career spanning over three decades, Giorgio Pifferi has held key roles in various research institutions and universities, where he has spearheaded numerous projects that have led to significant advancements in the scientific community.

Collaborations: Throughout his career, Giorgio Pifferi has collaborated with leading experts in the field, both nationally and internationally, fostering a culture of innovation and knowledge exchange that has been instrumental in his success as an inventor.

Conclusion: Giorgio Pifferi's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor in Milan, Italy, and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…